Key Financial Data Of Group

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7298417

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Net sales
42,466,000,000 JPY
75,579,000,000 JPY
36,978,000,000 JPY
Ordinary profit (loss)
2,237,000,000 JPY
6,142,000,000 JPY
3,465,000,000 JPY
Profit (loss) attributable to owners of parent
5,249,000,000 JPY
11,160,000,000 JPY
5,678,000,000 JPY
Comprehensive income
1,447,000,000 JPY
36,044,000,000 JPY
9,608,000,000 JPY
Net assets
220,770,000,000 JPY
221,136,000,000 JPY
201,628,000,000 JPY
Total assets
260,339,000,000 JPY
260,929,000,000 JPY
231,879,000,000 JPY
Basic earnings (loss) per share
118.75
246.61
123.66
Diluted earnings per share
Equity-to-asset ratio
0.844 xbrli:pure
0.843 xbrli:pure
0.865 xbrli:pure
Net cash provided by (used in) operating activities
2,775,000,000 JPY
-1,677,000,000 JPY
-2,333,000,000 JPY
Net cash provided by (used in) investing activities
2,779,000,000 JPY
8,690,000,000 JPY
3,653,000,000 JPY
Net cash provided by (used in) financing activities
-1,960,000,000 JPY
-10,006,000,000 JPY
-2,959,000,000 JPY
Cash and cash equivalents
49,440,000,000 JPY
45,887,000,000 JPY
47,251,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.